Personal information

Activities

Works (5)

Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report

Journal for ImmunoTherapy of Cancer
2023-02 | Journal article
Contributors: Karlijn de Joode; Sharon Veenbergen; Claudia Kransse; Dian Kortleve; Reno Debets; Ron H J Mathijssen; Arjen Joosse; Marco W J Schreurs; Astrid A M Van der Veldt
Source: check_circle
Crossref

The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies

2022-04-22 | Preprint
Contributors: K. de Joode; W.S. van de Geer; G.J.L.H. van Leenders; P. Hamberg; H.M. Westgeest; A. Beeker; S.F. Oosting; J.M. van Rooijen; L.V. Beerepoot; M. Labots et al.
Source: check_circle
Crossref

Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium

Neuro-Oncology
2022-02-01 | Journal article
Contributors: Karlijn de Joode; Walter Taal; Tom J Snijders; Monique Hanse; Johan A F Koekkoek; Esther Oomen - de Hoop; Jan Willem B de Groot; Mathilde C M Kouwenhoven; Laurens V Beerepoot; Anne-Marie C Dingemans et al.
Source: check_circle
Crossref

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium

European Journal of Cancer
2022-01 | Journal article
Contributors: Karlijn de Joode; Jolien Tol; Paul Hamberg; Marissa Cloos; Elisabeth A. Kastelijn; Jessica S.W. Borgers; Veerle J.A.A. Nuij; Yarne Klaver; Gerarda J.M. Herder; Pim G.N.J. Mutsaers et al.
Source: check_circle
Crossref

Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors

Journal for ImmunoTherapy of Cancer
2021-06 | Journal article
Contributors: Daan P. Hurkmans; Sebastiaan D.T. Sassen; Karlijn de Joode; Lisanne Putter; Edwin A. Basak; Annemarie J.M. Wijkhuijs; Markus Joerger; Reno Debets; Birgit C.P. Koch; Cor H. Van der Leest et al.
Source: check_circle
Crossref